Cefpodoxime Concentrations in Human Serum and Oral Tissues Following a Single Oral Administration of Cefpodoxime Proxetil
-
- Ono Makiko
- Departments of Oral Surgery, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan Resarch Institute of Oral Science, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan
-
- Omata Hiroaki
- Departments of Oral Surgery, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan
-
- Nishimura Hitoshi
- Departments of Oral Surgery, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan Resarch Institute of Oral Science, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan
-
- Tanaka Shigeo
- Departments of Oral Surgery, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan Resarch Institute of Oral Science, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan
-
- Matsumoto Hiroko
- Departments of Pharmacology, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan Resarch Institute of Oral Science, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan
-
- Fujii Akira
- Professor Emeritus, Nihon University, 4-8-24 Kudan-Minami, Chiyoda, Tokyo 102-8275, Japan
-
- Akimoto Yoshiaki
- Departments of Oral Surgery, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan
-
- Komiya Masamichi
- Departments of Oral Surgery, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan Resarch Institute of Oral Science, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, 271-8587, Japan
この論文をさがす
抄録
Cefpodoxime proxetil, an ester prodrug of cefpodoxime, is an oral third-generation cephalosporin antibiotic that is used for the treatment of odontogenic infections such as periodontitis, pericoronitis, and osteitis of jaw. However, there are only a few studies on cephalosporin concentrations in human oral tissues. The present study therefore was undertaken to determine cefpodoxime concentrations in human oral tissues following oral administration of cefpodoxime proxetil. Cefpodoxime concentrations in human serum, gingiva, mandibular bone, and dental follicle following a single oral administration of 200- mg cefpodoxime proxetil were measured by a paper disk method. The mean peak concentrations in serum, gingiva, mandibular bone, and dental follicle occurred at the same time point, 3 hours post-dose, and were 3.07 ± 0.96 μg/mL, 1.16 ± 0.35 μg/g, 0.60 ± 0.27 μg/g, and 1.13 ± 0.34 μg/g, respectively. Mean cefpodoxime concentration ratios of gingiva / serum, mandibular bone / serum, and dental follicle / serum at the peak time were 0.40 ± 0.15, 0.20 ± 0.05, and 0.37 ± 0.03, respectively. Mean concentrations in gingiva, mandibular bone, and dental follicle at the peak time exceeded the minimum inhibitory concentration for 80% of clinically isolated strains of oral streptococci. Therefore, cefpodoxime proxetil may be a valuable antimicrobial agent for the treatment of odontogenic infection.
収録刊行物
-
- IJOMS
-
IJOMS 14 (2-3), 48-53, 2016
日本大学松戸歯学部 口腔科学研究所
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205212732160
-
- NII論文ID
- 130005126920
-
- ISSN
- 21854254
- 13479733
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可